|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM355299496 |
| 003 |
DE-627 |
| 005 |
20231226064045.0 |
| 007 |
cr uuu---uuuuu |
| 008 |
231226s2023 xx |||||o 00| ||eng c |
| 024 |
7 |
|
|a 10.1080/02664763.2022.2041565
|2 doi
|
| 028 |
5 |
2 |
|a pubmed24n1184.xml
|
| 035 |
|
|
|a (DE-627)NLM355299496
|
| 035 |
|
|
|a (NLM)37025283
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Tzeng, ShengLi
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a On summary ROC curve for dichotomous diagnostic studies
|b an application to meta-analysis of COVID-19
|
| 264 |
|
1 |
|c 2023
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
| 338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
| 500 |
|
|
|a Date Revised 11.04.2023
|
| 500 |
|
|
|a published: Electronic-eCollection
|
| 500 |
|
|
|a Citation Status PubMed-not-MEDLINE
|
| 520 |
|
|
|a © 2022 Informa UK Limited, trading as Taylor & Francis Group.
|
| 520 |
|
|
|a In a systematic review of a diagnostic performance, summarizing performance metrics is crucial. There are various summary models in the literature, and hence model selection becomes inevitable. However, most existing large-sample-based model selection approaches may not fit in a meta-analysis of diagnostic studies, typically having a rather small sample size. Researchers need to effectively determine the final model for further inference, which motivates this article to investigate existing methods and to suggest a more robust method for this need. We considered models covering several widely-used methods for bivariate summary of sensitivity and specificity. Simulation studies were conducted based on different number of studies and different population sensitivity and specificity. Then final models were selected using several existing criteria, and we compared the summary receiver operating characteristic (sROC) curves to the theoretical ROC curve given the generating model. Even though parametric likelihood-based criteria are often applied in practice for their asymptotic property, they fail to consistently choose appropriate models under the limited number of studies. When the number of studies is as small as 10 or 5, our suggestion is best in different scenarios. An example for summary ROC curves for chemiluminescence immunoassay (CLIA) used in COVID-19 diagnosis is also illustrated
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
4 |
|a Summary ROC curve
|
| 650 |
|
4 |
|a meta analysis
|
| 650 |
|
4 |
|a random effects
|
| 650 |
|
4 |
|a sensitivity
|
| 650 |
|
4 |
|a specificity
|
| 650 |
|
4 |
|a systematic review
|
| 700 |
1 |
|
|a Chen, Chun-Shu
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Li, Yu-Fen
|e verfasserin
|4 aut
|
| 700 |
1 |
|
|a Chen, Jin-Hua
|e verfasserin
|4 aut
|
| 773 |
0 |
8 |
|i Enthalten in
|t Journal of applied statistics
|d 1991
|g 50(2023), 6 vom: 30., Seite 1418-1434
|w (DE-627)NLM098188178
|x 0266-4763
|7 nnns
|
| 773 |
1 |
8 |
|g volume:50
|g year:2023
|g number:6
|g day:30
|g pages:1418-1434
|
| 856 |
4 |
0 |
|u http://dx.doi.org/10.1080/02664763.2022.2041565
|3 Volltext
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 50
|j 2023
|e 6
|b 30
|h 1418-1434
|